Investor Relations

High-growth medical device company and market leader within single-use endoscopy

Latest news

11

May. 2026

Transactions under Ambu’s share buyback program

On 6 May 2026, Ambu announced a share buyback program (company announcement no. 12 2025/26). The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations.                                                                                            

During the program, Ambu will repurchase shares for a total amount of up to DKK 300m from 6 May 2026 until no later than 30 September 2026. The repurchased shares are bought with the aim of completing a share capital decrease as set out in Article 5(2)(a) in MAR.

The following transactions have been made under the program from 6 May 2026 to 8 May 2026:

 Number of sharesAverage purchase price, DKKTransaction value, DKK
Accumulated under the program after last announcement00.00000
2026.05.06250,00062.124615,531,150
2026.05.0747,00062.27642,926,991
2026.05.0819,49161.92491,206,978
Accumulated under the program316,49162.134819,665,105


After the above disclosed transactions DKK 280,334,895 remains to be repurchased. Ambu now owns 4,511,649 treasury shares, corresponding to 1.5% of the share capital.

Download the company announcement here.

07

May. 2026

Reporting of transactions made by persons discharging managerial responsibilities (no. 13)

Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S and/or their closely associated persons related to Ambu A/S’s shares admitted to trading and official listing on Nasdaq Copenhagen A/S.

This attached document discloses the data of the transactions made by Executive Management.

 
Read the full company announcement here.

06

May. 2026

Ambu initiates new share buyback program (no. 12)

Copenhagen, Denmark, 6 May 2026 – Ambu A/S is initiating a new share buyback program, under which Ambu will repurchase shares for a total amount of up to DKK 300m from 6 May 2026 until no later than 30 September 2026. 

The share buyback program is being launched within the authority granted by the shareholders at the annual general meeting held on 14 December 2022, for the repurchase of up to 10% of the company’s share capital, provided that the purchase price does not deviate by more than 10% from the most recently quoted market price for the company’s B-shares at the time of the acquisition. Prior to the launch of the share buyback program, Ambu holds 4,195,158 treasury shares, equal to 1.6% of the company’s share capital. 

The share buyback program is carried out in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) (as amended) and the Commission Delegated Regulation (EU) 2016/1052 of 8 March 2016, also referred to as the Safe Harbor Regulations, with the purpose of completing a share capital decrease as set out in Article 5(2)(a) in MAR. 

Ambu has retained Nordea Bank to act as lead manager of the share buyback program and purchase shares on behalf of Ambu. Nordea Bank has also agreed under the contract to make its trading decisions in relation to the shares in the company independently of, and without influence by, the company.

Ambu will be entitled to suspend the share buyback program at any time. Should the share buyback program be suspended, Ambu will announce this in a company announcement, and the manager will stop buying back shares in the market. The repurchased shares are bought with the aim of future cancellation. 

Terms of the share buyback program 
Under the share buyback program, Ambu may repurchase shares up to a maximum amount of DKK 300m, and no more than 6,000,000 shares, corresponding to approximately 2.2% of the share capital of the company.

The shares will be purchased on Nasdaq Copenhagen (XCSE) and Multilateral Trading Facilities from time to time, including Cboe DXE (CEUX), Turquoise Europe (TQEX), and Aquis (AQEU). 

The shares bought back on each trading day may not exceed 15% of the average daily trading volume over the 20 trading days preceding the date of purchase. 

Shares acquired under the share buyback program may not be bought at a price exceeding the higher of (i) the share price of the last independent transaction, and (ii) the highest independent bid on the shares on the trading venue where the transaction is executed. Further, shares may not be bought at a price deviating by more than 10% from the official price quoted on Nasdaq Copenhagen at the time of acquisition for the company’s B-shares. 

In accordance with the Safe Harbor Regulations, Ambu will as a minimum for every seventh trading day issue an announcement in respect of transactions made under the share buyback program. 

Download the company announcement here.

Ambu presented at the JP Morgan 2026 healthcare conference

Download the PDF presentation delivered by Ambu CEO Britt Meelby Jensen

 

Financial Reports

Get the latest annual & quarterly reports
Read more

Annual Key Figures

Get an overview of Ambu's key figures
Read more

Presentations

Get the latest investor presentations and webcasts
Read more

Upcoming events

26

Aug. 2026

Earnings release Q3 2025/26

30

Sep. 2026

End of fiscal year 2025/26

05

Nov. 2026

Annual report 2025/26

News from Ambu

Sign up and receive financial news and company announcements from Ambu

Sign up

 

keyboard_arrow_up